This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

October 19-22, 2020
Now Delivered 100% Virtually,
in Eastern Standard Time (EST)

The cell and gene therapy event for ground breaking bioprocessing, manufacturing & supply chain strategies

World renowned leaders share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene edited ex vivo cell therapy programs

EARLY BIRD DISCOUNT!

Register your team by Friday 28th August to save up to $300

Introduction Video


by Sarah Lintern

Conference Director, Cell & Gene Therapy Portfolio 

Interested in speaking opportunities? Or, if you have any questions about the event, please reach out directly:

Sarah.Lintern@informa.com

REDEFINING YOUR LEARNING EXPERIENCE

In light of the current global climate, it is more important than ever for the cell & gene therapy community to connect with one another, strategize and share ideas – All in a safe, responsible way. With our dedication to address the most pressing issues, our cell and gene therapy events, now taking place October 19 - 22, have undergone a timely transformation, moving to an all-digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.


UNIQUE BENEFITS OF THIS ALL-VIRTUAL EVENT:
UNIQUE BENEFITS OF THIS ALL-VIRTUAL EVENT:

• Customizable agenda with access to expanded session offerings
• Convenient session scheduling for increased productivity
• On-demand access to content and topic resources
• Interactive presentations/panels for reinforced learning
• Pointed problem-solving and solution sourcing
• Broader industry benchmarking and post-event analytics/insights
• Elevated and direct access to thought leaders and experts

POWER OF NETWORKING:
POWER OF NETWORKING:

Who’s Who?
Attendee and company profiles provide insight into the delegation and sponsoring organizations
Advanced search capabilities to identify opportunities and potential partners

When and How to Connect?

Sophisticated and seamless scheduling tools to establish meeting times
Ease-of-use technology to enable virtual networking


DIGITAL CAPABILITIES AND FEATURES:
DIGITAL CAPABILITIES AND FEATURES:

• Access to Virtual Environment
• Audience Q&A
• Live Polling
• Expert-Led Problem-Solving
• Virtual Networking and Partnering

COMPREHENSIVE CONTENT AND DYNAMIC FEATURES:
COMPREHENSIVE CONTENT AND DYNAMIC FEATURES:

• 4 Days of Live Keynotes
• 25+ On-Demand Sessions
• Over 8 Hours of Live Speaker Q&A and Interactive Roundtables
• Networking with Industry Colleagues and Counterparts

Why Choose Cell & Gene Therapy Bioprocessing & Commercialization Virtual?


Our Cell & Gene Therapy Virtual Conference & Exhibition is not just another webinar or zoom call.  


Watch our highlight video and see why the global cell therapy industry chooses our event ground breaking bioprocessing, manufacturing & supply chain strategies.

IN-DEPTH ON-DEMAND CONTENT — WHAT YOU WANT. WHEN YOU WANT IT

Access all of the extensively researched agenda and sessions with the novelty of being able to view it at your own pace. How? All presentations will be made available both live and on-demand for 30 days, so you will be able to attend more presentations than ever before! Have 2 live sessions that you want to attend at the same time? Now you can watch one live and watch the other on-demand at a time that suits you.


Adherent Cell Manufacturing & Process Development


Lior Raviv, Vice President Development & Operations, Pluristem Therapeutics Inc., Israel

Will Allogeneic Cell Therapies Replace the Current Autologous Models?


Geoffrey Hodge, formerly, Chief Technical Officer, Unum Therapeutics Inc., USA

Development of Modern Biologics and Cell Therapy Products Through Global CMOs


Vadim Klyushnichenko, VP Pharmaceutical Development & Quality, Calibr & Scripps Research, USA


Assessing the Future Prospects of Upstream Bioprocessing Systems for Commercial AAV Production


Scott Jeffers, Director, UniQure, USA

Raw Materials: BOMs, Risks & Securing Supply


Tom Walls, Associate Director Supply Chain, bluebird bio, USA

Sourcing Appropriate Starting and Ancillary Materials for Manufacturing Cell and Gene Therapy Products


Kathy Williams, VP Quality & Reg Affairs, RoosterBio Inc., USA


Pathogen Safety Margins for Gene Therapy Manufacturing


Thomas R. Kreil, VP, Global Head Pathogen Safety, Takeda Inc., Austria

Exposing the Content of Different AAV Fractions after Ultracentrifugation  
 
David Dobnik, Senior Research Associate, National Institute of Biology, Slovenia  

The Case for rAAV Titration by HPLC

Franz Schnetzinger, Director Quality Control & CMC Analytical Development, Gyroscope Therapeutics Limited, UK 


AI in Cell and Gene Therapy Manufacturing


Michael Roberts, Chief Technology Officer (Europe), Asklepios
BioPharmaceutical, Inc., UK

Potency & Fully Characterizing your Cell Product


Amandine Breton, Cell Therapy Operations Manager, Orchard Therapeutics, UK (pending final confirmation)

Product Dependent Cryopreservation Protocols

David McKenna, Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota, USA  


Fresh vs. Cryopreserved: Tightening up Supply Chains


Jason Acker, Professor, Laboratory Medicine and Pathology, University of Alberta, Canada  


Implementation of “off the shelf” Closed Systems fit for every purpose


Ali Mohamed, VP, CMC, Immatics, USA

Re- Dosing: Is Gene Therapy Really a Cure?


Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences, USA

Poster Presentation

Consider presenting a poster at this virtual event to derive more value from attending. Share your research with your peers and learn from other posters as well. Many attendees tell us that being selected for a poster presentation helps to facilitate their company approval process to attend the event. Submit your poster abstract online today using the form below.

Deadline: 4th September 2020

CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2020 VIRTUALLY

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

(Companies A-L) Contact Kristin Skahan: Kristin.Skahan@informa.com | +1-857-504-6730 

(Companies M-Z) Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 (0)20 7017 7247 


Event Partners

Get the latest event updates

Sign up to get the latest event updates and information.